Dosing has begun in a long-term extension study testing Satellos Bioscience’s experimental oral therapy SAT-3247 in men with ...

Columnist Betty Vertin doesn't often dwell on her caregiver grief, but sometimes she needs to embrace it and let it flow through her.

In a $12 billion deal, Novartis has agreed to acquire Avidity Biosciences, which is developing several treatments for ...